Literature DB >> 10906025

Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management.

D Hacking1, R Smyth, N Shaw, G Kokia, H Carty, D Heaf.   

Abstract

BACKGROUND: Pulmonary interstitial fibrosis in children is a disease of unknown aetiology, usually associated with a poor prognosis.
METHODS: In this case series we describe 11 children presenting over a 10 year period, managed conservatively and associated with a good prognosis.
RESULTS: In six, symptoms were present from birth and 10 had symptoms at or before 3 months. Diagnosis was made using chest computed tomography and percutaneous lung biopsy. All patients were treated with oral prednisolone. In five no steroid response was noted. One patient responded to hydroxychloroquine. Home oxygen was required in five patients. At follow up all patients are alive at a median age of 6 years (range 1 to 12 years). The two recently diagnosed children have significant symptoms, seven have dyspnoea on exercise, and two are symptom free.
CONCLUSION: The good prognosis seen in these patients is different to previous case reports, indicating a greater than 50% mortality.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906025      PMCID: PMC1718422          DOI: 10.1136/adc.83.2.152

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  33 in total

1.  Anthropometric indices of failure to thrive.

Authors:  P Raynor; M C Rudolf
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

2.  Deliberate sulphonylurea poisoning mimicking hyperinsulinaemia of infancy.

Authors:  L Owen; M Ellis; J Shield
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

Review 3.  Controversy: Sedation of children for magnetic resonance imaging.

Authors:  G R Lawson
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

4.  School based screening for hypothyroidism in Down's syndrome by dried blood spot TSH measurement.

Authors:  S E Noble; K Leyland; C A Findlay; C E Clark; J Redfern; J M Mackenzie; R W Girdwood; M D Donaldson
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

5.  Lung deposition of aerosol--a comparison of different spacers.

Authors:  H J Zar; E G Weinberg; H J Binns; F Gallie; M D Mann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

6.  Desquamative fibrosing alveolitis unresponsive to steroid or cytotoxic therapy.

Authors:  S E Barnes; S Godfrey; G H Millward-Sadler; N R Roberton
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

7.  Controversy: Is the Children Act failing severely abused and neglected children?

Authors:  N Speight; J Wynne
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

Review 8.  Is routine growth monitoring effective? A systematic review of trials.

Authors:  P Garner; R Panpanich; S Logan
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

9.  Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa.

Authors:  H J Zar; E Tannenbaum; P Apolles; P Roux; D Hanslo; G Hussey
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

10.  The concept of classic interstitial pneumonitis-fibrosis (CIP-F) as a clinicopathologic syndrome.

Authors:  R A DeRemee; E G Harrison; H A Andersen
Journal:  Chest       Date:  1972-03       Impact factor: 9.410

View more
  2 in total

Review 1.  Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints.

Authors:  Gloria Pelizzo; Serena Silvestro; Maria Antonietta Avanzini; Gianvincenzo Zuccotti; Emanuela Mazzon; Valeria Calcaterra
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

2.  A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis.

Authors:  Chana I C Chin; Shirleen Loloyan Kohn; Thomas G Keens; Monique F Margetis; Roberta M Kato
Journal:  Orphanet J Rare Dis       Date:  2015-08-20       Impact factor: 4.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.